Coherus Biosciences | 营业费用



金融业
股票价格
USD
资产
USD 516.52M
现金及等价物
USD 103.35M
销售成本
USD 2.65M
流动资产
USD 460.96M
流动负债
USD 372.3M
债务
USD 294.93M
股息收益率
0
EBIT
USD -45.44M
EBITDA
USD -44.34M
员工
306
EPS每股收益
USD -0.35
股本和储备
USD 87.77M
销售毛利
USD 4.95M
债务利息支出
USD 2.15M
贷款资金
USD 294.85M
市值
USD 237.8M
净收入
USD -56.57M
营业费用
USD 53.03M
营业利润
USD -45.44M
普通股股本
USD 12K
税前利润
USD -47.4M
销售收入
USD 7.6M
销售和管理费用
USD 26.03M
股票
USD 2.05M
贸易债权人
USD 24.89M
应收帐款人
USD 62.44M


营业费用 更改 日
AbbVie USD 10.81B 13.45B 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amarin USD 51.37M 14.6M 2025-09
Amgen USD 5.9B 773M 2025-12
Baxter International USD 2.63B 95.8M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Coherus Biosciences USD 53.03M 43.41M 2025-03
Eli Lilly USD 10.31B 1.09B 2025-12
Fujifilm JPY 767.39B 27.7B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Merck USD 10.16B 558M 2025-12
Myriad Genetics USD 229M 3.4M 2025-09
Pacira USD 166.36M 4.5M 2025-09
Perrigo USD 949.9M 50.8M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09
Xencor USD 68.52M 8.26M 2025-09
Zoetis USD 5.4B 3.94B 2025-09


Coherus Biosciences 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.